Yue Guan

1 month ago | tandfonline.com | Yue Guan |Christian Göbel

ABSTRACTAuthoritarian regimes use participatory institutions to gather information from citizens, but the gathered information is often overwhelming. To examine what receives leaders’ attention amid this overload, we analyzed communications from two Chinese e-government platforms that published local Party and government heads’ written instructions (pishi) in response to individual citizen submissions.

Dec 17, 2023 | lexology.com | Yue Guan

IntroductionFactsDecisionCommentIntroductionOn 10 August 2023, China National Intellectual Property Administration (CNIPA) issued two invalidation decisions, No. 561725 (Decision 1) and No. 562232 (Decision 2). These were in response to invalidity requests filed by the same petitioner against AbbVie's two core patents related to its blockbuster drug Upadacitinib. Decision 1 declared the patentee's compound patent ZL201080062920.6 invalid in its entirety.

Nov 3, 2023 | managingip.com | Yue Guan

On August 10 2023, the China National Intellectual Property Administration (CNIPA) issued two invalidation decisions, No. 561725 (Decision #1) and No. 562232 (Decision #2), in response to invalidity requests filed by the same petitioner against AbbVie’s two core patents related to its blockbuster drug upadacitinib. Decision #1 declared the patentee’s compound patent ZL201080062920.6 invalid in its entirety.